In the phase 2 trial, the Bharat Biotech-ICMR’s COVID-19 vaccine showed better reactogenicity and safety outcomes, and enhanced humoral and cell-mediated immune responses compared with the...
Covaxin is one of the two COVID-19 vaccines to have got emergency use license in India and is being used in India’s vaccination programme
Covishield, a locally manufactured version by Pune’s Serum Institute of India and the indigenous Covaxin, from the Hyderabad-based company Bharat Biotech are the two COVID-19 vaccines...
The first interim analysis is based on 43 cases, of which 36 cases of COVID-19 were observed in the placebo group versus seven cases observed in...
Speaking at the Global Bio-India 2021, World Health Organization's Chief Scientist Soumya Swaminathan said that the fight against the coronavirus pandemic is at a very critical...
People above 60 and those over 45 with comorbidities began getting their vaccines from March 1 in the second phase of vaccination drive, that is estimated...
On March 1, COVID vaccination was rolled out for people above 60 and those above 45 years of age with comorbidities
The second phase of the nationwide COVID-19 vaccination drive for age-appropriate population groups (people above 60 and those with comorbidities above 45) began on March 1
Johnson & Johnson's COVID-19 vaccine is different from the other two already on the market- Pfizer/BioNTech and Moderna as it is to be administered in a...
Johnson & Johnson’s COVID-19 vaccine does not need to be kept in a freezer and can be stored at refrigerated temperatures, said CDC’s Director Rochelle Walensky
The second phase of COVID-19 vaccination in India began on March 1; leaders took the first jab, set an example for others
Hospitals are gearing up for the second phase of COVID-19 vaccinations, as the government aims to vaccinate over 27 crore people, out of whom around 10...
